阿替普酶静脉溶栓联合心理干预治疗急性脑梗死临床分析

Clinical Analysis of Alteplase Intravenous Thrombolysis Combined with Psychological Intervention in the Treatment of Acute Cerebral Infarction

目的评估阿替普酶静脉溶栓给药治疗加心理干预治疗方案实施在急性脑梗死患者临床治疗过程中的价值。方法便利选取2018年4月—2019年12月该医院诊治的68例急性脑梗死患者开展数据项目具体计算,予以分组方式参考随机双盲方式,不同组别各自纳入34例,实验组采用阿替普酶静脉溶栓给药治疗加心理干预治疗方案,参比组采用阿替普酶静脉溶栓给药治疗干预方案,统计干预有效总体占比数据、满意总体占比数据。结果实验组干预有效总体占比数据(97.06%)相比参比组对应指标资料(79.41%)加大(χ^2=5.100,P=0.023<0.05);实验组满意总体占比数据(97.06%)相比参比组对应指标资料(76.47%)加大(χ^2=6.275,P=0.012<0.05)。结论为急性脑梗死患者选用阿替普酶静脉溶栓给药治疗加心理干预治疗方案表明较好临床治疗效果。

Objective To evaluate the value of intravenous thrombolytic administration of alteplase plus psychological intervention in the clinical treatment of patients with acute cerebral infarction.Methods The data items of 68 patients with acute cerebral infarction diagnosed and treated convenient selection in the hospital from April 2018 to December 2019 were calculated.The grouping method was based on the random double-blind method.34 cases were included in different groups.The experimental group used alteplase intravenous thrombolytic administration treatment plus psychological intervention treatment plan,the reference group used alteplase intravenous thrombolytic administration treatment intervention plan,statistics on the overall proportion of effective intervention data and satisfactory overall proportion data.Results The data(97.06%)of the total effective intervention in the experimental group is larger than the corresponding index data(79.41%)of the reference group(χ~2=5.100,P=0.023<0.05);the data of the experimental group was satisfied with the overall data(97.06%)compared with the corresponding index data(76.47%)of the reference group,the data increased(χ~2=6.275,P=0.012<0.05).Conclusion The choice of intravenous thrombolytic therapy with alteplase plus psychological intervention for patients with acute cerebral infarction indicates a better clinical treatment effect.